Summary
John Johnson is an experienced biostatistician and owner-principal at RJS Data Science, providing senior statistical leadership and part-time consulting to small biotechs and emerging pharma for over 13 years. He has led large, complex Phase 3 and late-stage trials and managed programming and biostatistics teams, with deep expertise in adaptive designs, Bayesian methods, regulatory submissions, and FDA engagement. His background includes senior roles at PPD, Mapi, Cato Research, and Rho, where he combined hands-on analysis, software for power/sample-size, and mentorship of statistical staff. A UNC Chapel Hill Ph.D. in Statistics, he’s known for translating advanced statistical strategies into practical development paths that accelerate drug development while keeping regulatory risk low.
13 years of coding experience
4 years of employment as a software developer
Diploma, HIGH SCHOOL/SECONDARY DIPLOMAS AND CERTIFICATES, Diploma, HIGH SCHOOL/SECONDARY DIPLOMAS AND CERTIFICATES at North Carolina School of Science and Mathematics
PGM Class
Coursera
Ph.D., Statistics, Ph.D., Statistics at The University of North Carolina at Chapel Hill
French